Marrow Cellution™ vs. Traditional BMA Harvest Project

Launched by OHIO STATE UNIVERSITY · Apr 24, 2024

Keywords

ClinConnect Summary

This clinical trial is examining two different methods for collecting bone marrow liquid, which is important for healing in patients with hip conditions like bone loss, subchondral cysts, and avascular necrosis. The study will involve six patients aged 18 to 50 who are undergoing a minimally invasive hip surgery. Participants will have bone marrow collected from both their surgical hip and their non-surgical hip using two different systems: the standard Zimmer Biomet Biocue system and the new Marrow Cellutions™ system. The bone marrow collected will be processed to concentrate the healing cells, and while the concentrated liquid from the Zimmer Biomet system will be used during surgery, the one from the Marrow Cellutions™ system will be analyzed in a lab.

To be eligible for this trial, patients must be between 18 and 50 years old and scheduled for hip surgery due to specific bone issues. However, individuals with certain medical histories, such as blood disorders or diabetes, will not be included. Participants can expect to have their bone marrow collected and analyzed, but only the standard treatment will be used during their surgery. This study is focused on understanding how these different collection methods may impact healing in the hip area.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients aged 18 - 50
• • patients undergoing hip arthroscopy for subchondral bone cysts and/or avascular necrosis
• Exclusion Criteria:
• • patients with a history of hematologic issues including anemia and sickle cell anemia
• • patients with a history of leukemia, lymphoma, or other bone marrow related diseases
• • patients with diabetes
• • patients with a history of bone marrow aspirate